CAS Search
Related Chemical Product
Buy Chemical NO: 52-01-7
  • Urgent Purchase CAS NO.:52-01-7
  • Please post your buying leads! Our suppliers will contact you later!
  • For suppliers to better understand your request, enter more info here.

* Product Name:
CAS No.:
* Quantity:
 
 Metric Ton     Kilogram    Gram    Pound
* Valid For:
 5 Days    15    1 Month    3 Month    6 Month    1 Year
* Description:

Max 2000 characters.  Please enter detailed description for the product.
* Email:
 

Spironolactone ( CASNO:52-01-7 )

Identification and Related Records
Name:
Spironolactone
CAS Registry number:
52-01-7
Synonyms:
Alderon
3-(3-Keto-7.alpha.-acetylthio-17.beta.-hydroxy-4-androsten-17.alph a.-yl)propionic acid lactone
Uractone
Spiro(17H-cyclopenta(a)phenauthrene-17,2-(3H)-furan)
Xenalon
Pregn-4-ene-21-carboxylic acid,7-(acetylthio)-17-hydroxy-3-oxo-,?- lactone,(7R,17R)-
Aldactone
17.alpha.-Pregn-4-ene-21-carboxylic acid, 17-hydroxy-7.alpha.-mercapto-3-oxo-, .gamma.-lactone, acetate
Euteberol
Prestwick_449
Pregn-4-ene-21-carboxylic acid, 7-(acetylthio)-17-hydroxy-3-oxo-, gamma-lactone, (7alpha,17alpha)-
Spironolactone A
Urusonin
Verospirone
SC 9420
SC 15983
Spiro(17H-cyclopenta(a)phenanthrene-17,2(5H)-furan), pregn-4-ene-21-carboxylic acid deriv.
Spiro-Tablinen
Spirolang
Spironolactone [BAN:INN:JAN]
7-alpha-Acetylthio-3-oxo-17-alpha-pregn-4-ene-21,17-beta-carbolactone
7-alpha-(acetylthio)-17-alpha-hydroxy-3-oxopregn-4-ene-21-carboxylic acid, gamma-lactone (9CI)
496916-40-6
Spironolactonum [INN-Latin]
Aldactone A
Aldactazide (TN)
Spiroctan
3-(3-Oxo-7-alpha-acetylthio-17-beta-hydroxyandrost-4-en-17-beta-yl)propionic acid lactone
7-(Acetylthio)-17-hydroxy-3-oxopregn-4-ene-21-carboxylic acid gamma-lactone
Pregn-4-ene-21-carboxylic acid, 7-(acetylthio)-17-hydroxy-3-oxo-, g-lactone, (7a,17a)-
Verospiron
EINECS(EC#):
200-133-6
Molecular Formula:
C24H32O4S
Molecular Weight:
416.57
Inchi:
InChI=1/C24H32O4S/c1-14(25)29-19-13-15-12-16(26)4-8-22(15,2)17-5-9-23(3)18(21(17)19)6-10-24(23)11-7-20(27)28-24/h12,17-19,21H,4-11,13H2,1-3H3/t17-,18-,19+,21+,22-,23-,24+/m0/s1
InChIKey:
LXMSZDCAJNLERA-PJKOONHHSA-N
Canonical SMILES:
CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C
Isomers smiles:
CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)
C)CCC(=O)O5)C
Chemical and Physical Properties
Appearance:
White powder.
Density:
1.24g/cm3
Melting Point:
198-207℃
Boiling Point:
597℃ at 760mmHg
Refractive Index:
-36 ° (C=1, CHCl3)
Flash Point:
302.3℃
Alpha:
-37 ° (C=1, CHCL3)
Water:
practically insoluble
Solubilities:
practically insoluble
Color/Form:
Crystals from methanol
Light cream-colored to light tan, crystalline powder
Stability:
Stable under normal temperatures and pressures.
Storage temp:
Keep container closed when not in use. Store in a cool, dry, well-ventilated area away from incompatible substances.
Spectral properties:
Specific optical rotation = -33.5 deg (chloroform)
UV max: 238 nm (epsilon 20200)
Computed Properties:
Molecular Weight:416.57348 [g/mol]
Molecular Formula:C24H32O4S
XLogP3:2.9
H-Bond Donor:0
H-Bond Acceptor:5
Rotatable Bond Count:2
Tautomer Count:10
Exact Mass:416.20213
MonoIsotopic Mass:416.20213
Topological Polar Surface Area:85.7
Heavy Atom Count:29
Formal Charge:0
Complexity:818
Isotope Atom Count:0
Defined Atom Stereocenter Count:7
Undefined Atom Stereocenter Count:0
Defined Bond Stereocenter Count:0
Undefined Bond Stereocenter Count:0
Covalently-Bonded Unit Count:1
Feature 3D Acceptor Count:2
Feature 3D Ring Count:5
Effective Rotor Count:4.2
Conformer Sampling RMSD:0.8
CID Conformer Count:1
Safety and Handling
Hazard Codes:
T:Toxic
Risk Statements:
R40;R60
Safety Statements:
S53;S22;S36/37/39;S45
Formulations/Preparations:
SPIRONOLACTONE & HYDROCHLOROTHIAZIDE: ALDACTAZIDE (SEARLE). ORAL: EACH TABLET CONTAINS SPIRONOLACTONE 25 MG & HYDROCHLOROTHIAZIDE 25 MG.
Oral: Tablets, film-coated: 25 mg Aldactone (with povidone), (Pfizer) Spironolactone Tablets (Mutual), Spironolactone Tablets (Mylan), Spironolactone Tablets (Sandoz), Spironolactone Tablets (UDL), Spironolactone Tablets, (United Research); 50 mg Aldactone (with povidone; scored), (Pfizer), Spironolactone Tablets (Actavis), Spironolactone Tablets (Mutual), Spironolactone Tablets (Mylan), Spironolactone Tablets (United Research); 100 mg Aldactone (with povidone; scored), (Pfizer), Spironolactone Tablets (Actavis), Spironolactone Tablets (Mutual), Spironolactone Tablets (Mylan), Spironolactone Tablets (United Research).
aldactone
aldactone a
spiresis
spiridon
spirolang
spirone
uractone
verospiron
verospirone
Exposure Standards and Regulations:
The Approved Drug Products with Therapeutic Equivalence Evaluations List identifies currently marketed prescription drug products, incl spironolactone, approved on the basis of safety and effectiveness by FDA under sections 505 of the Federal Food, Drug, and Cosmetic Act.
Specification:
The Spironolactone, with the cas registry number 52-01-7, has the IUPAC name of S-[(7R,8R,9S,10R,13S,14S,17R)-10,13-dimethyl-3,5'-dioxospiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-oxolane]-7-yl] ethanethioate. This is a kind of white to off white solid, and is practically insoluble. Its product categories are including Active Pharmaceutical Ingredients; Biochemistry; Steroids; Steroids (Others); Intermediates & Fine Chemicals; Pharmaceuticals; API's. As to its usage, it is a kind of diuretic and also used as an antiandrogen.
The physical properties of this chemical are as follows: (1)ACD/LogP: 3.12; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 3.12; (4)ACD/LogD (pH 7.4): 3.12; (5)ACD/BCF (pH 5.5): 139.34; (6)ACD/BCF (pH 7.4): 139.34; (7)ACD/KOC (pH 5.5): 1192.14; (8)ACD/KOC (pH 7.4): 1192.14; (9)#H bond acceptors: 4; (10)#H bond donors: 0; (11)#Freely Rotating Bonds: 2; (12)Polar Surface Area: 85.74; (13)Index of Refraction: 1.585; (14)Molar Refractivity: 112.68 cm3; (15)Molar Volume: 335.7 cm3; (16)Polarizability: 44.67 ×10-24 cm3; (17)Surface Tension: 50.8 dyne/cm; (18)Density: 1.24 g/cm3; (19)Flash Point: 302.3 °C; (20)Enthalpy of Vaporization: 88.93 kJ/mol; (21)Boiling Point: 597 °C at 760 mmHg; (22)Vapour Pressure: 3.24E-14 mmHg at 25°C; (23)Exact Mass: 416.20213; (24)MonoIsotopic Mass: 416.20213; (25)Topological Polar Surface Area: 85.7; (26)Heavy Atom Count: 29; (27)Formal Charge: 0; (28)Complexity: 818.
When you are dealing with this chemical, you should be very cautious. For being a kind of irritant chemical to eyes, respiratory system and skin, it may cause inflammation to the skin or other mucous membranes. Then it is harmful which may cause damage to health. What's more, it is even toxic which could at low levels cause damage to health. This chemical may have impair fertility and may have limited evidence of a carcinogenic effect.
Therefore, you should take the following instructions to protect yourself. Wear suitable protective clothing, gloves and eye/face protection and avoid exposure - obtain special instructions before use. If in case of accident or if you feel unwell seek medical advice immediately (show the label where possible), and if in case of contact with eyes, rinse immediately with plenty of water and seek medical advice. Then do remember not breathe dust. When store it, keep in a dry, cool and well-ventilated place, away from the food raw material.
In addition, you could convert the following datas into the molecular structure:
(1)Canonical SMILES: CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C
(2)Isomeric SMILES: CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C
(3)InChI: InChI=1S/C24H32O4S/c1-14(25)29-19-13-15-12-16(26)4-8-22(15,2)17-5-9-23(3)18(21(17)19)6-10-24(23)11-7-20(27)28-24/h12,17-19,21H,4-11,13H2,1-3H3/t17-,18-,19+,21+,22-,23-,24+/m0/s1
(4)InChIKey: LXMSZDCAJNLERA-ZHYRCANASA-N
Below are the toxicity information of this chemical:
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
human TDLo oral 5600mg/kg (5600mg/kg) KIDNEY, URETER, AND BLADDER: URINE VOLUME INCREASED Journal of Laboratory and Clinical Medicine. Vol. 80, Pg. 224, 1972.
man TDLo oral 5714ug/kg/4D- (5.714mg/kg) LUNGS, THORAX, OR RESPIRATION: "FIBROSIS, FOCAL (PNEUMOCONIOSIS)"

BLOOD: AGRANULOCYTOSIS

BLOOD: CHANGES IN CELL COUNT (UNSPECIFIED)
Drug Intelligence and Clinical Pharmacy. Vol. 21, Pg. 974, 1987.
man TDLo oral 7500ug/kg/3W- (7.5mg/kg) BLOOD: AGRANULOCYTOSIS Australian and New Zealand Journal of Medicine. Vol. 30, Pg. 515, 2000.
man TDLo oral 7500ug/kg/3W- (7.5mg/kg) BLOOD: AGRANULOCYTOSIS

BLOOD: CHANGES IN BONE MARROW NOT INCLUDED ABOVE
Australian and New Zealand Journal of Medicine. Vol. 30, Pg. 515, 2000.
mouse LD50 intraperitoneal 260mg/kg (260mg/kg) ? Drugs in Japan Vol. 6, Pg. 381, 1982.
mouse LD50 intravenous 260mg/kg (260mg/kg) ? Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 9, Pg. 759, 1967.
mouse LD50 oral > 1gm/kg (1000mg/kg) ? Journal of Environmental Pathology and Toxicology. Vol. 1(5), Pg. 641, 1978.
rabbit LD50 intraperitoneal 866mg/kg (866mg/kg) Journal of Environmental Pathology and Toxicology. Vol. 1(5), Pg. 641, 1978.
rabbit LD50 oral > 1gm/kg (1000mg/kg) Journal of Environmental Pathology and Toxicology. Vol. 1(5), Pg. 641, 1978.
rat LD50 intraperitoneal 277mg/kg (277mg/kg) Drugs in Japan Vol. 6, Pg. 381, 1982.
rat LD50 oral > 1gm/kg (1000mg/kg) Drugs in Japan Vol. 6, Pg. 381, 1982.
women TDLo oral 70mg/kg/5W-I (70mg/kg) BLOOD: AGRANULOCYTOSIS British Medical Journal. Vol. 289, Pg. 731, 1984.
women TDLo oral 122mg/kg/61D- (122mg/kg) KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)" New Zealand Medical Journal. Vol. 83, Pg. 147, 1976.
Octanol/Water Partition Coefficient:
log Kow = 2.78
Disposal Methods:
SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.
Use and Manufacturing
Use and Manufacturing:
Methods of Manufacturing
US PATENT 3013012 (1961 TO SEARLE)
Usage:
It is a synthetic 17-lactone steroid which is a renal competitive aldosterone antagonist in a class of pharmaceuticals called potassium-sparing diuretics, used primarily to treat ascites in patients with liver disease, low-renin hypertension, hypok.
Biomedical Effects and Toxicity
Biological Activity:
Competitive mineralocorticoid (aldosterone) receptor antagonist that exhibits antihypertensive activity in vivo . Also displays antiandrogen activity and inhibits steroid hormone biosynthesis.
Pharmacological Action:
- Compounds which inhibit or antagonize the biosynthesis or actions of aldosterone.
- Agents that promote the excretion of urine through their effects on kidney function.
Therapeutic Uses:
Aldosterone Antagonists; Diuretics
EXPL THER: Aldosterone is important in the pathophysiology of heart failure. In a doubleblind study, we enrolled 1663 patients who had severe heart failure and a left ventricular ejection fraction of no more than 35 percent and who were being treated with an angiotensin-converting-enzyme inhibitor, a loop diuretic, and in most cases digoxin. A total of 822 patients were randomly assigned to receive 25 mg of spironolactone daily, and 841 to receive placebo. The primary end point was death from all causes. The trial was discontinued early, after a mean follow-up period of 24 months, because an interim analysis determined that spironolactone was efficacious. There were 386 deaths in the placebo group (46 percent) and 284 in the spironolactone group (35 percent; relative risk of death, 0.70; 95 percent confidence interval, 0.60 to 0.82; P<0.001). This 30 percent reduction in the risk of death among patients in the spironolactone group was attributed to a lower risk of both death from progressive heart failure and sudden death from cardiac causes. The frequency of hospitalization for worsening heart failure was 35 percent lower in the spironolactone group than in the placebo group (relative risk of hospitalization, 0.65; 95 percent confidence interval, 0.54 to 0.77; P<0.001). In addition, patients who received spironolactone had a significant improvement in the symptoms of heart failure, as assessed on the basis of the New York Heart Association functional class (P<0.001). Gynecomastia or breast pain was reported in 10 percent of men who were treated with spironolactone, as compared with 1 percent of men in the placebo group (P<0.001). The incidence of serious hyperkalemia was minimal in both groups of patients. [Pitt B et al; N Engl J Med 341 (10): 709-17 (1999)]
Biomedical Effects and Toxicity:
At the time spironolactone was introduced for clinical use, its bioavailability was inadequate, and this was improved by preparing the drug in finely powdered or micronized form. The absolute bioavailability was indirectly estimated at approximately 73%, which was enhanced in the presence of food. Nearly all absorbed spironolactone (> 90 %) is bound to plasma proteins and, with repeated dosing, a steady state is achieved within 8 days. After oral intake of a 100-mg dose, the plasma half-time of spironolactone was 1-2 h, the time to maximum plasma concentration was 2-3.2 hr, the maximum blood concentration was 92-148 ng/mL, the area under the concentration--time (0-24 hr) curve was 1430-1541 ng/mL per hr and the elimination half-time was 18-20 hr.
The disposition of (14)C spironolactone was studied in male rats, female dogs and female monkeys after intravenous or oral administration of 5 mg/kg bw. Gastrointestinal absorption was estimated to be 82% in rats, 62% in dogs and 103% in monkeys. Spironolactone was extensively metabolized in all three species, and the metabolites were excreted primarily in the urine and feces. The amount of radiolabel excreted in urine or feces of all three species was similar after intravenous and after oral dosing. In monkeys, as in humans, the amounts excreted in urine and feces were about equal, while fecal excretion predominated in rats and dogs as a result of biliary excretion. After the oral dose, the percentage of urinary excretion was 4.7% in rats, 18% in dogs and 46% in monkeys. The high excretion of radiolabel in the feces of rats (90%) after intravenous administration shows the importance of biliary excretion for that species. Species differences were also noted in the biotransformation of spironolactone.
Absorption of spironolactone from the GI tract depends on the formulation in which it is administered. Currently available formulations of spironolactone are well absorbed from the GI tract and bioavailability of the drug exceeds 90% when compared to an optimally absorbed spironolactone solution in polyethylene glycol 400. Following a single oral dose of spironolactone, peak serum concentrations of the drug occur within 1-2 hours, and peak serum concentrations of its principal metabolites are attained within 2-4 hours. When spironolactone is administered concomitantly with food, peak serum concentrations and areas under the serum concentration-time curves (AUCs) of the drug and, to a lesser degree, its principal metabolites are increased substantially compared with the fasting state.
Spironolactone and canrenone, a major metabolite of the drug, are both more than 90% bound to plasma proteins. Spironolactone or its metabolites may cross the placenta. Canrenone, a major metabolite of spironolactone, is distributed into milk.
Environmental Fate and Exposure Potential
Environmental Fate/Exposure Summary:
TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 770(SRC), determined from a log Kow of 2.78(2) and a regression-derived equation(3), indicates that spironolactone is expected to have low mobility in soil(SRC). Volatilization of spironolactone from moist soil surfaces is not expected to be an important fate process(SRC) given an estimated Henry's Law constant of 1.1X10-10 atm-cu m/mole(SRC), using a fragment constant estimation method(4). Spironolactone is not expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 3.2X10-11 mm Hg(SRC), determined from a fragment constant method(5). Biodegradation data were not available(SRC, 2007).
AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 770(SRC), determined from a log Kow of 2.78(2) and a regression-derived equation(3), indicates that spironolactone is expected to adsorb to suspended solids and sediment(SRC). Volatilization from water surfaces is not expected(3) based upon an estimated Henry's Law constant of 1.1X10-10 atm-cu m/mole(SRC), developed using a fragment constant estimation method(4). According to a classification scheme(5), an estimated BCF of 27(SRC), from its log Kow(2) and a regression-derived equation(6), suggests the potential for bioconcentration in aquatic organisms is low(SRC). Biodegradation data were not available(SRC, 2007).
ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), spironolactone, which has an estimated vapor pressure of 3.2X10-11 mm Hg at 25 deg C(SRC), determined from a fragment constant method(2), is expected to exist solely in the particulate phase in the ambient atmosphere. Particulate-phase spironolactone may be removed from the air by wet or dry deposition(SRC). Spironolactone does not absorb light at wavelengths >290 nm(4) and therefore is not expected to be susceptible to direct photolysis by sunlight(SRC).
Chemical Company
Haining Rishine LED Lighting CO.,LTD:
Haining Rishine LED lighting CO., LTD was established in 2013,Website:http://www.rishineled.net,which is a manufacturer and trader company specialized in the research, development and production of LED panel. We are located in Haining,with convenient transportation access. Rishine company depending on the quality of life, services for the market concept, through continuous efforts and perfect, has passed ISO9001 certification, the European CE certification, ROSH certification and TUV certification. Our products through strict testing to ensure the excellent quality of products.  
shijiazhuang jike chemicals:
 
Wuxi Hengnuo Chemical Equipment Manufacturing Co.,Ltd.:
Wuxi Hengnuo Chemical Equipment Manufacturing Co. Ltd. is a chemical,Website:http://www.reactiontank.com, cosmetic, pharmaceutical, bio engineering and other equipment manufacturers, have been designed to side feeding stainless steel cutting machine, according to the production practice over the years to perfect the equipment efficiency.  
Hebei Huihua Pharmaceutical Co., Ltd.:
Hebei Huihua Pharmaceutical Co., Ltd., is really a comprehensive corporation focused on the study, development,production, personalization and buying and selling from the API's intermediates and fine chemicals. You will find independent R&D center and inspection center in Huihua, thus we could track and control all procedures of products (for example Pharmaceutical Intermediates) from small-scale test and pilot scale experiment to industrial production. Furthermore, we purchase leading experiment and inspection facilities and establish complete inspection system and QA system, thus we love solid guarantees to provide clients quality items. You're welcomed to become along with us in the manner to get the happy existence through our mutual efforts.  
Chengzhi Life Science Co.,Ltd.:
 
order prednisone, wirykg," target="_blank">order prednisone, wirykg,:
 
Enshi Heno Biologic Engineering Co.,Ltd:
 
465724SX54ScsdaAD:
 
Shanghai Golden Aerosol Co.,Ltd.:
Shanghai Golden Aerosol Co., Ltd is a company focused on researching, developing, manufacturing and selling aerosol items. Situated in Wanxiang Industry Park, Lingang xincheng, Pudong New Area,it possessed standard plant, and five full-automatic production lines introduced from abroad for aerosol valve. It's the advanced niche for aerosol metering valve in China. Now, The primary items are: aerosol metering valve, aerosol special valve, and air-perfume spray machine. Aerosol metering valve includes: 1 " and 20mm metering valve (dosages are 35u, 50ul, 75ul, 100ul, 120ul ,150ul and 200ul)aerosol special valve includes: fire extinguisher valve, hammer nailed valve, 1 " and 20mm valve in bag, certainly, the research group of we are awaiting researching other special aerosol valve for that cus 
Yongkang HongQing crafts& arts Co.,ltd.:
Yongkang Hongqing crafts & arts co.,Ltd. is a seasonal decorations factory which was found in 2007 in Yongkang,Website:http://www.festivaltinsel.com,zhejiang,china. Fully equipped factory premises located in yongkang of Zhejiang Province of China, with straight production facilities of molding, produce tinsel garland & assembling crafts . Strong R&D, QA, QC teams and workforce are qualified to develop OEM projects of Consumer Products and to assure the quality strictest up to ISO9001.on and Fast delivery. The Company is specialized in supplying all kinds of seasonal decorations as displayed in the following pages of this Website, and also act as Agent for Clients in Europe, South Africa, Australia, canana and South America etc. to undertake sourcing, purchasing, shipment control and f 
Elite Machinery & Equipment Co., Ltd.:
Elite Machinery & Equipment Co.,Ltd is an unite company,Website:http://www.eltmachine.com,and we have three independent branch factories.we are a professional manufacturer and supplier of concrete machine. our products are the following: ----JS twin-shaft concrete mixer;----JSD twin-shaft concrete mixer;----HZS skip hoist concrete batching plant;----HZS belt conveyor concrete batching plant;----YHSZ mobile concrete batching plant;----MHZS modular concrete batching plant;----SNC bolted cement silo;----LS cement screw conveyor 
mukala products limited:
 
tjxuanchisusan:
 
Tianjin Topsino Imp&Exp Co., Ltd:
Tianjin Topsino Imp&Exp Co., Ltd. settled in Tianjin Beichen Economic Development Zone in 2007 with prediction based on linepipe steel selling. We also have other pipes,Website:http://www.topsino-steelpipe.com, plates, profiles customization, processing, logistics service. The core concept of our company is established that is " innovative services as the foundation, comprehensive service to establish the core idea of the brand", combined with the overall strength of the enterprise. The service content of steel trading company is defined again and the full seamless service tracking system is established. Our company is taking strategic transformation from trading company to service company. For eight years, service brand has went deep into hundreds of enterprises such as the world's five h 
Zhangjiakou City Fangzhou Chemicals Goods Co, Ltd:
ZHANGJIAKOU CITY FANGZHOU CHEMICALS GOODS SALES CO.,LTD is made in Zhangjiakou city in northern China since 1998, which has more than 13 years experience of chemical raw material production ,research and Export.Caffeine raw material consists of organic and inorganic chemicals that are broadly utilized in paint, dyestuff, rubber,water treatment, Detergent, leather, Paper- making Industry and the like · The items includealuminum sulfate 15.8%-17%,calcium chloride 74%/94%,Sodium Hexametaphosphate 68%,sodium metabisulphite 64%,carbon black N220/N330/N550/N660,Zinc 99%/99.5%-99.7%,oxalic acidity 99.6%,formic Acidity 85%/90%,Neopentyl glycol,pentaerythritol 95%/98%,rediron oxide,yellow iron oxide,carboxy methy lcellulose CMC,lithopone 28%/30%,titanium dioxide rutile/anatase and the like 
Chongqing Beauty Abundant Trade Co.,Ltd.:
Chongqing Beauty Abundant Trade Co.,Ltd.a company focusing in Zinc ingots,Aluminum Ingots,Container Ingots,copper ingots,magnesium ingots,ETC. Locationg in China, our organization occupies section of 42000 square kilometers and has modern workshop of 30000 square kilometres, Our total investment has arrived at over RMB 100 million. We have over 300 employees including 18 engineers with middle or high technical title.   We have great manufacturing capacity of annual 6000 tons alumina section, 10000 tons casting alloy ingots, 20 teams of leisure aluminum items and 1000 tons aluminum goods, and Our items happen to be offered to a lot of nations and districts for example European, American, Middle East and the like. We always take people because the foremost, attach importance to qua 
Zhejiang Chiral Medicine Chemicals Co.,Ltd.:
Founded in 1998,Hangzhou Chiral Medicine Chemicals Co.,Ltd is situated at Zhejiang Nanyang Economic Development Zone, occupies a place of 15000m2. The organization is focused on pharmaceutical intermediates and Materials, continues to be approved High-tech enterprise of Zhejiang province. Hangzhou CMC鐣俧fers effective manufacturing abilities permanently quality items made to satisfy customers' needs. Thus far, we've developed all of the items and the organization supports the property legal rights, together with a Chinese patent. At the moment, you will find 90 employees in the organization included in this 25% are senior specialists and managers. The competitive ascendancy of the organization is principally centered on strong analytical and R&D Personnel. Continuously developing h 
shanghai nanchuang pharmaticals Co.,Ltd:
 
JSY Modular House Co., Ltd:
Beijing Oriental Shengbo is a professional manufacturer of steel structure building,Website:http://www.china-housemakers.com, prefabricated house, light steel villa. We are devoted to offer healthy and eco-friendly new building materials products and improve the living house of humans. Now our business and products involve from design, develop, produce and sale new light steel structure of villa to the whole house construction materials including roof system, wall system, floor system etc. light steel structure widely use for different areas please check as follows: Residential House Commercial House Industrial Building Public Facilities Housing Material We adhere to technological innovation, develop new products to offer more healthy, eco-friendly and sustainable h 
SHANDONG HEDA INDUSTRY CO.,LIMITED: